IP Library Granted Patent US 9,068,891
Granted Patent B2
US 9,068,891 · App. 13/734,600 · Granted Jun 30, 2015

Method and apparatus for measuring concentration of biogenic substance

Inventors: Masahiko Shioi (Kyoto, JP); Kristof Lodewijks (Lommel, BE); Pol Van Dorpe (Spalbeek, BE); Hilde Jans (Heverlee, BE)
Assignees: PANASONIC CORPORATION; IMEC vzw; Katholieke Universiteit Leuven, K.U.Leuven R&D
G01J3/4412G01N21/658
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,068,891
App. No.
13/734,600
Granted
Jun 30, 2015
Kind
B2
Abstract

A method for measuring a concentration of a biogenic substance in a living body includes steps of: preparing an apparatus including a light source, a substrate which has periodic metal structures and generates surface enhanced Raman scattering light by being irradiated with light from the light source, and spectroscopic means which disperses and detects the light, wherein the periodic metal structure is arranged with first and second distances in first and second direction respectively, the first distance is set to generate surface plasmon by matching a phase of the light from the light source, and the second distance is smaller than the first distance and is set between 300 nm and 350 nm; irradiating the substrate with the light from the light source to generate the surface enhanced Raman scattering; detecting the scattering with the spectroscopic means; and calculating the concentration of the biogenic substance based on the scattering.

Claims (25)

1. A method for measuring a concentration of a biogenic substance, comprising steps of:

(a) preparing an apparatus for biogenic substance concentration measurement,

said apparatus comprising a light source, a polarization controller which controls a polarization of the light from said light source, a substrate which has periodic metal structures and generates surface enhanced Raman scattering light by being irradiated with light emitted from said light source, and spectroscopic means which disperses and detects said surface enhanced Raman scattering light, wherein

said periodic metal structure is arranged with a first distance in a first direction and with a second distance in a second direction,

said first distance is set to generate surface plasmon by matching a phase of the light emitted by said light source, and

said second distance is smaller than said first distance and the second distance is set between 300 nm and 350 nm;

(b) irradiating the substrate with the light emitted from the light source so as to generate the surface enhanced Raman scattering, wherein the polarization of said light is controlled along with said first direction by said polarization controller;

(c) detecting said generated surface enhanced Raman scattering with said spectroscopic means;

(d) recording an intensity of said surface enhanced Raman scattering detected in step (c);

(e) irradiating the substrate with the light emitted from the light source so as to generate the surface enhanced Raman scattering, wherein the polarization of said light is changed by said polarization controller;

(f) detecting said generated surface enhanced Raman scattering at said step (e) with said spectroscopic means;

(g) recording an intensity of said surface enhanced Raman scattering detected in step (f);

(h) determining a larger intensity of surface enhanced Raman scattering and recording said larger intensity by comparing the recorded intensity of the surface enhanced Raman scattering at said step (g) with the recorded intensity of the surface enhanced Raman scattering at step (d);

(i) calculating the maximum intensity of surface enhanced Raman scattering by repeating the steps of (e) to (h);

(j) calculating the concentration of the biogenic substance on the basis of said maximum intensity of surface enhanced Raman scattering calculated in said step (i).

2. A method according to claim 1 , wherein

said first direction and said second direction are perpendicular to each other.

3. A method according to claim 1 , wherein

said substrate is arranged in a sample solution containing the biogenic substrate; and

the concentration of the biogenic substance contained in the test solution is measured.

4. A method according to claim 1 , wherein

said substrate is implanted into a skin of a living body; and

the concentration of the biogenic substance contained in the living body is measured.

5. A method according to claim 1 , wherein

said biogenic substance is glucose.

Assignments (2)
CHANGE OF NAME Recorded Jan 16, 2015
From: IMEC
To: IMEC VZW
Reel/Frame 034892/0016 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 29, 2013
From: SHIOI, MASAHIKO; LODEWIJKS, KRISTOF; VAN DORPE, POL; JANS, HILDE
To: PANASONIC CORPORATION; INTERUNIVERSITAIR MICRO-ELEKTRONICA CENTRUM; KATHOLIEKE UNIVERSITEIT LEUVEN,K.U.LEUVEN R&D
Reel/Frame 030498/0488 →
Priority Claims (1)
JP 2012-001479 · Jan 6, 2012 · national
Continuity (1)
Related Publication 20130176562A1 · Jul 11, 2013